AdvanSix Inc. 10-Q

ITEM 1. FINANCIAL STATEMENTS ADVANSIX INC. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) (Dollars in thousands, except share and per share amounts) Three Months Ended March 31, 2022 2021 Sales $ 479,073 $ 376,383 Costs, expenses and other: Costs of goods sold 375,646 317,899 Selling, general and administrative expenses 21,210 19,308 Interest expense, net 563 1,544 Other non-operating (income) expense, net ( 603 ) 230 Total costs, expenses and other 396,816 338,981 Income before taxes 82,257 37,402 Income tax expense 19,184 9,271 Net income $ 63,073 $ 28,131 Earnings per common share Basic $ 2.24 $ 1.00 Diluted $ 2.15 $ 0.98 Weighted average common shares outstanding Basic 28,199,871 28,093,764 Diluted 29,371,051 28,741,066 See accompanying notes to Condensed Consolidated Financial Statements. 3 ADVANSIX INC. CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited) (Dollars in thousands) Three Months Ended March 31, 2022 2021 Net income $ 63,073 $ 28,131 Foreign exchange translation adjustment 57 ( 70 ) Cash-flow hedges 512 483 Other comprehensive income (loss), net of tax 569 413 Comprehensive income $ 63,642 $ 28,544 See accompanying notes to Condensed Consolidated Financial Statements. 4 ADVANSIX INC. CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Dollars in thousands, except share and per share amounts) March 31, 2022 December 31, 2021 ASSETS Current assets: Cash and cash equivalents $ 19,306 $ 15,100 Accounts and other receivables – net 223,541 179,087 Inventories – net 163,396 149,570 Other current assets 6,220 6,097 Total current assets 412,463 349,854 Property, plant and equipment – net 782,783 767,964 Operating lease right-of-use assets 132,567 136,207 Goodwill 57,863 17,592 Intangible assets 48,948 17,980 Other assets 22,497 22,402 Total assets $ 1,457,121 $ 1,311,999 LIABILITIES Current liabilities: Accounts payable $ 200,524 $ 211,511 Accrued liabilities 40,203 49,712 Income taxes payable 27,656 9,723 Operating lease liabilities – short-term 36,435 36,127 Deferred income and customer advances 2,434 2,749 Total current liabilities 307,252 309,822 Deferred income taxes 145,206 133,330 Operating lease liabilities – long-term 96,471 100,580 Line of credit – long-term 220,000 135,000 Postretirement benefit obligations 19,451 18,243 Other liabilities 10,350 13,834 Total liabilities 798,730 710,809 COMMITMENTS AND CONTINGENCIES (Note 9) STOCKHOLDERS' EQUITY Common stock, par value $ 0.01 ; 200,000,000 shares authorized; 31,900,305 shares issued and 28,103,293 outstanding at March 31, 2022; 31,755,430 shares issued and 28,139,954 outstanding at December 31, 2021 319 318 Preferred stock, par value $ 0.01 ; 50,000,000 shares authorized and 0 shares issued and outstanding at March 31, 2022 and December 31, 2021 — — Treasury stock at par ( 3,797,012 shares at March 31, 2022; 3,615,476 shares at December 31, 2021) ( 38 ) ( 36 ) Additional paid-in capital 193,321 195,931 Retained earnings 470,759 411,516 Accumulated other comprehensive loss ( 5,970 ) ( 6,539 ) Total stockholders' equity 658,391 601,190 Total liabilities and stockholders' equity $ 1,457,121 $ 1,311,999 See accompanying notes to Condensed Consolidated Financial Statements. 5 ADVANSIX INC. CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (Dollars in thousands) Three Months Ended March 31, 2022 2021 Cash flows from operating activities: Net income $ 63,073 $ 28,131 Adjustments to reconcile net income to net cash provided by operating activities: Depreciation and amortization 16,692 16,104 Loss on disposal of assets 359 84 Deferred income taxes ( 519 ) 2,237 Stock-based compensation 3,374 2,363 Accretion of deferred financing fees 155 141 Changes in assets and liabilities, net of business acquisitions: Accounts and other receivables ( 28,402 ) ( 13,170 ) Inventories ( 1,889 ) 38,986 Accounts payable ( 8,029 ) ( 13,781 ) Income taxes payable 17,933 — Accrued liabilities ( 11,718 ) 912 Deferred income and customer advances ( 315 ) ( 6,803 ) Other assets and liabilities ( 1,552 ) 1,886 Net cash provided by operating activities 49,162 57,090 Cash flows from investing activities: Expenditures for property, plant and equipment ( 21,019 ) ( 14,177 ) Acquisition of business ( 98,589 ) ( 9,523 ) Other investing activities ( 296 ) ( 231 ) Net cash used for investing activities ( 119,904 ) ( 23,931 ) Cash flows from financing activities: Borrowings from line of credit 148,500 54,000 Payments of line of credit ( 63,500 ) ( 83,000 ) Principal payments of finance leases ( 237 ) ( 199 ) Dividend payments ( 3,517 ) — Purchase of treasury stock ( 7,012 ) ( 443 ) Issuance of common stock 714 1 Net cash provided by (used for) financing activities 74,948 ( 29,641 ) Net change in cash and cash equivalents 4,206 3,518 Cash and cash equivalents at beginning of period 15,100 10,606 Cash and cash equivalents at the end of period $ 19,306 $ 14,124 Supplemental non-cash investing activities: Capital expenditures included in accounts payable $ 7,335 $ 2,965 Supplemental cash activities: Cash paid for interest $ 408 $ 1,518 Cash paid for income taxes $ 22 $ 35 See accompanying notes to Condensed Consolidated Financial Statements. 6 ADVANSIX INC. CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) (Dollars in thousands) Common Stock Additional Paid-In Capital Retained Earnings Treasury Stock Accumulated Other Comprehensive Income (Loss) Total Equity Shares Amount Balance at December 31, 2021 31,755,430 $ 318 $ 195,931 $ 411,516 $ ( 36 ) $ ( 6,539 ) $ 601,190 Net Income — — — 63,073 — — 63,073 Comprehensive income Foreign exchange translation adjustments — — — — — 57 57 Cash-flow hedges — — — — — 512 512 Pension obligation adjustments — — — — — — — Other comprehensive income (loss), net of tax — — — — — 569 569 Issuance of common stock 144,875 1 713 — — — 714 Purchase of treasury stock ( 181,536 shares) — — ( 7,010 ) — ( 2 ) — ( 7,012 ) Stock-based compensation — — 3,374 — — — 3,374 Dividends — — 313 ( 3,830 ) — — ( 3,517 ) Balance at March 31, 2022 31,900,305 $ 319 $ 193,321 $ 470,759 $ ( 38 ) $ ( 5,970 ) $ 658,391 Common Stock Additional Paid-In Capital Retained Earnings Treasury Stock Accumulated Other Comprehensive Income (Loss) Total Equity Shares Amount Balance at December 31, 2020 31,627,139 $ 316 $ 184,732 $ 275,243 $ ( 36 ) $ ( 16,132 ) $ 444,123 Net Income — — — 28,131 — — 28,131 Comprehensive income Foreign exchange translation adjustments — — — — — ( 70 ) ( 70 ) Cash-flow hedges — — — — — 483 483 Pension obligation adjustments — — — — — — — Other comprehensive income (loss), net of tax — — — — — 413 413 Issuance of common stock 33,200 1 — — — — 1 Purchase of treasury stock ( 15,371 shares) — — ( 443 ) — — — ( 443 ) Stock-based compensation — — 2,363 — — — 2,363 Balance at March 31, 2021 31,660,339 $ 317 $ 186,652 $ 303,374 $ ( 36 ) $ ( 15,719 ) $ 474,588 See accompanying notes to Condensed Consolidated Financial Statements. 7 ADVANSIX INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Dollars in thousands, except share and per share amounts and as otherwise noted) 1. Organization, Operations and Basis of Presentation Description of Business AdvanSix Inc. ("AdvanSix," the "Company," "we" or "our") plays a critical role in global supply chains, innovating and delivering essential products for our customers in a wide variety of end markets and applications that touch people’s lives, such as building and construction, fertilizers, agrochemicals, plastics, solvents, packaging, paints, coatings, adhesives and electronics. Our reliable and sustainable supply of quality products emerges from the integrated value chain of our five U.S.-based manufacturing facilities. AdvanSix strives to deliver best-in-class customer experiences and differentiated products in the industries of nylon solutions, chemical intermediates and plant nutrients, guided by our core values of Safety, Integrity, Accountability and Respect. COVID-19 Since early 2020, the novel coronavirus (COVID-19) has continued to spread, with confirmed cases worldwide, and with certain jurisdictions experiencing resurgences, including as a result of variant strains. The pandemic and related containment measures, such as travel bans and restrictions, shelter in place orders and business shutdowns, have had a substantial impact on businesses around the world and on global, regional and national economies, including disruptions to supply chains, volatility in demand, production and sales across most industries, volatility within global financial markets, inflationary pressures in commodity pricing and an increasingly dynamic workforce environment. The continuously evolving nature of this pandemic and the pace and shape of a full recovery may continue to have an impact on the United States and global economies. The Company’s Condensed Consolidated Financial Statements reflect estimates and assumptions made by management that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Condensed Consolidated Financial Statements and reported amounts of revenue and expenses during the reporting periods presented. The Company continues to consider the impact of COVID-19 on the estimates and assumptions used for the financial statements. As previously disclosed, the Company experienced a material impact on its second quarter 2020 results of operations associated with lower demand, particularly in nylon, caprolactam and phenol, and a decrease in overall sales volume related to global markets and the economic impact of COVID-19. Starting in the second half of 2020, and through the first quarter of 2022, demand improved to pre-COVID-19 levels with states, regions and countries in various phases of re-opening and continued administration of vaccines for COVID-19. The Company will continue to monitor developments and execute our operational and safety mitigation plans as previously disclosed. As the situation surrounding COVID-19 remains fluid and unpredictable, the Company cannot reasonably estimate with any degree of certainty the future impact COVID-19 may have on the Company’s results of operations, financial position, and liquidity. Basis of Presentation The Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and with the instructions to Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, the accompanying unaudited Condensed Consolidated Financial Statements contain all adjustments, consisting of only normal recurring adjustments, necessary for a fair statement of the Company's financial position as of March 31, 2022, and its results of operations for the three months ended March 31, 2022 and 2021 and cash flows for the three months ended March 31, 2022 and 2021. The year-end Condensed Consolidated Balance Sheet data were derived from audited financial statements but does not include all disclosures required by U.S. GAAP. The results of operations of any interim period are not necessarily indicative of the results of operations to be expected for the full fiscal year. These financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2021 (the "2021 Form 10-K"). All intercompany transactions have been eliminated. Certain prior period amounts have been reclassified for consistency with the current period presentation. It is our practice to establish actual quarterly closing dates using a predetermined fiscal calendar, which requires our businesses to close their books on a Saturday in order to minimize the potentially disruptive effects of quarterly closing on our business processes. Historically, the effects of this practice were generally not significant to reported results for any quarter and only 8 ADVANSIX INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Dollars in thousands, except share and per share amounts and as otherwise noted) existed within a reporting year. In the event that differences in actual closing dates are material to year-over-year comparisons of quarterly or year-to-date results, we will provide the appropriate disclosures. Our actual closing dates for the three months ended March 31, 2022 and 2021 wer e April 2, 2022 and April 3, 2021, respe ctively. Liabilities to creditors to whom we have issued checks that remained outstanding at March 31, 2022 and December 31, 2021 aggregated to $ 2.2 million and $ 4.5 million, respectively, and were included in Cash and cash equivalents and Accounts payable in the Condensed Consolidated Balance Sheets. On May 4, 2018, the Company announced that its Board of Directors (the “Board”) authorized a share repurchase program of up to $ 75 million of the Company’s common stock. On February 22, 2019, the Company announced that the Board authorized a share repurchase program of up to an additional $ 75 million of the Company's common stock, which was in addition to the remaining capacity available under the May 2018 share repurchase program. Repurchases may be made from time to time on the open market in accordance with Rule 10b-18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), including through the use of trading plans intended to qualify under Rule 10b5-1 of the Exchange Act. The size and timing of these repurchases will depend on pricing, market and economic conditions, legal and contractual requirements and other factors. The share repurchase program has no expiration date and may be modified, suspended or discontinued at any time. The par value of the shares repurchased is applied to Treasury stock and the excess of the purchase price over par value is applied to Additional paid-in capital. During the first quarter of 2022, the Company repurchased 181,536 shares of common stock, including 57,968 shares to cover tax withholding obligations in connection with the vesting of awards, for an aggregate of $ 7.0 million at a weighted average market price of $ 38.61 per share. As of March 31, 2022, the Company had repurchased 3,797,012 shares of common stock, including 583,682 shares withheld to cover tax withholding obligations in connection with the vesting of awards, for an aggregate of $ 109.4 million at a weighted average market price of $ 28.81 per share. As of March 31, 2022, $ 54.8 million remained available for share repurchases under the current authorization. During the period April 1, 2022 through April 29, 2022, no additional shares were repurchased under the currently authorized repurchase program. 2. Recent Accounting Pronouncements Recent Accounting Pronouncements – The Company considers the applicability and impact of all Accounting Standards Updates (“ASUs”) issued by the Financial Accounting Standards Board (“FASB”). Any ASUs not currently adopted were assessed and determined to be either not applicable or are expected to have minimal impact on our consolidated financial position or results of operations. 3. Revenues Revenue Recognition We serve approximately 400 customers annually in approximately 50 countries and across a wide variety of industries. For the three months ended March 31, 2022 and 2021, the Company's ten largest customers accounted for approximately 37 % and 38 % of total sales, respectively. We typically sell to customers under master service agreements, with primarily one-year terms, or by purchase orders. We have historically experienced low customer turnover and have long-standing customer relationships, which span decades. Our largest customer is Shaw Industries Group, Inc. (“Shaw”), a significant consumer of caprolactam and Nylon 6 resin, to whom we sell under a long-term agreement. For the three months ended March 31, 2022 and 2021, the Company's sales to Shaw were 9 % and 12 % of our total sales, respectively. The Company's revenue by product line, and related approximate percentage of total sales, for the three months ended March 31, 2022 and 2021 were as follows: 9 ADVANSIX INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Dollars in thousands, except share and per share amounts and as otherwise noted) Three Months Ended March 31, 2022 2021 Nylon $ 118,609 25 % $ 83,789 22 % Caprolactam 70,005 15 % 80,403 21 % Chemical Intermediates 135,690 28 % 141,360 38 % Ammonium Sulfate 154,769 32 % 70,831 19 % $ 479,073 100 % $ 376,383 100 % The Company's revenues by geographic area, and related approximate percentage of total sales, for the three months ended March 31, 2022 and 2021 were as follows: Three Months Ended March 31, 2022 2021 United States $ 403,018 84 % $ 300,672 80 % International 76,055 16 % 75,711 20 % Total $ 479,073 100 % $ 376,383 100 % Deferred Income and Customer Advances The Company defers revenues when cash payments are received in advance of our performance. Below is a roll-forward of Deferred income and customer advances for the three months ended March 31, 2022: Opening balance January 1, 2022 $ 2,749 Additional cash advances 640 Less amounts recognized in revenues ( 955 ) Ending balance March 31, 2022 $ 2,434 The Company expects to recognize as revenue the March 31, 2022 ending balance of Deferred income and customer advances within one year or less. 4. Earnings Per Share The computation of basic and diluted earnings per share ("EPS") is based on Net income divided by the basic weighted average number of common shares and diluted weighted average number of common shares, respectively. The details of the basic and diluted EPS calculations for the three months ended March 31, 2022 and 2021 were as follows: Three Months Ended March 31, 2022 2021 Basic Net income $ 63,073 $ 28,131 Weighted average common shares outstanding 28,199,871 28,093,764 EPS – Basic $ 2.24 $ 1.00 Diluted Dilutive effect of equity awards and other stock-based holdings 1,171,180 647,302 Weighted average common shares outstanding 29,371,051 28,741,066 EPS – Diluted $ 2.15 $ 0.98 10 ADVANSIX INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Dollars in thousands, except share and per share amounts and as otherwise noted) Diluted EPS is computed based upon the weighted average number of common shares outstanding for the period plus the dilutive effect of common stock equivalents using the treasury stock method and the average market price of our common stock for the period. The diluted EPS calculations exclude the effect of stock options when the options’ assumed proceeds exceed the average market price of the common shares during the period. The anti-dilutive common stock equivalents outstanding at the three months ended March 31, 2022 and 2021 were as follows: Three Months Ended March 31, 2022 2021 Options and stock equivalents 120,316 861,376 Dividend activity for the three months ended March 31, 2022 and 2021 was as follows: Three Months Ended March 31, 2022 2021 Cash dividends declared per share $ 0.125 $ — Aggregate dividends paid to shareholders $ 3,517 $ — 5. Accounts and Other Receivables – Net March 31, 2022 December 31, 2021 Accounts receivables $ 220,010 $ 175,584 Other 4,870 4,998 Total accounts and other receivables 224,880 180,582 Less – allowance for doubtful accounts ( 1,339 ) ( 1,495 ) Total accounts and other receivables – net $ 223,541 $ 179,087 6. Inventories March 31, 2022 December 31, 2021 Raw materials $ 90,299 $ 56,961 Work in progress 52,578 43,526 Finished goods 57,374 27,961 Spares and other 27,679 27,150 227,930 155,598 Reduction to LIFO cost basis ( 64,534 ) ( 6,028 ) Total inventories $ 163,396 $ 149,570 Substantially all of the Company’s inventories at March 31, 2022 and December 31, 2021 are valued at the lower of cost or market using the last-in, first-out (“LIFO”) method. However, approximately 9 % was valued at average cost using the first-in, first-out (“FIFO”) method at March 31, 2022. The excess of replacement cost over the carrying value of total inventories subject to LIFO was $ 72.5 million and $ 29.4 million at March 31, 2022 and December 31, 2021, respectively. 7. Leases We determine if an arrangement is a lease at inception. Operating leases are included in Operating lease right-of-use assets ("ROU"), Operating lease liabilities – short-term, and Operating lease liabilities – long-term in our Condensed Consolidated Balance Sheets. Finance leases are included in Property, plant and equipment – net, Accounts payable, and Other liabilities in our Condensed Consolidated Balance Sheets. 11 ADVANSIX INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Dollars in thousands, except share and per share amounts and as otherwise noted) The components of lease expense were as follows: Three Months Ended March 31, 2022 2021 Finance lease cost: Amortization of right-of-use asset $ 236 $ 183 Interest on lease liabilities 14 8 Total finance lease cost 250 191 Operating lease cost 10,339 11,571 Short-term lease cost 1,353 1,913 Total lease cost $ 11,942 $ 13,675 As of March 31, 2022, we have additional finance leases that have not yet commenced for approximately $ 0.5 million. These leases will commence during 2022 with lease terms of up to 5 years. 8. Goodwill and Intangible Assets Intangible assets with finite lives acquired through a business combination are recorded at fair value, less accumulated amortization. Customer relationships and trade-names are amortized on a straight-line basis over their expected useful lives of 15 to 20 years and 5 years, respectively. Goodwill The change in the carrying amount of goodwill was as follows: Total Balance at December 31, 2021 $ 17,592 Acquisition of U.S. Amines 40,271 Balance at March 31, 2022 $ 57,863 Finite-Lived Intangible Assets Intangible assets subject to amortization were as follows: March 31, 2022 December 31, 2021 Gross Carrying Amount Accumulated Amortization Net Book Value Gross Carrying Amount Accumulated Amortization Net Book Value Customer relationships $ 34,220 $ ( 423 ) $ 33,797 $ 3,920 $ ( 240 ) $ 3,680 Licenses 18,451 ( 4,382 ) 14,069 18,451 ( 4,151 ) 14,300 Trade names 1,100 ( 18 ) 1,082 — — — Total $ 53,771 $ ( 4,823 ) $ 48,948 $ 22,371 $ ( 4,391 ) $ 17,980 For the three months ended March 31, 2022 and March 31, 2021, the Company recorded amortization expense on intangible assets of $ 0.4 million and $ 0.3 million, respectively. 9. Commitments and Contingencies The Company is subject to a number of lawsuits, investigations and disputes, some of which may involve substantial amounts claimed, arising out of the conduct of the Company or other third-parties in the normal and ordinary course of business. A liability is recognized for any contingency that is probable of occurrence and reasonably estimable. The Company continually assesses the likelihood of adverse judgments or outcomes in these matters, as well as potential ranges of possible losses, based 12 ADVANSIX INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Dollars in thousands, except share and per share amounts and as otherwise noted) on an analysis of each matter with the assistance of legal counsel and, if applicable, other experts. Given the uncertainty inherent in such lawsuits, investigations and disputes, the Company does not believe it is possible to develop estimates of reasonably possible loss in excess of current accruals for these matters. Considering the Company’s past experience and existing accruals, the Company does not expect the outcome of these matters, either individually or in the aggregate, to have a material adverse effect on the Company’s consolidated financial position or results of operations. Potential liabilities are subject to change due to new developments, changes in settlement strategy or the impact of evidentiary requirements, which could cause the Company to pay damage awards or settlements (or become subject to equitable remedies) that could have a material adverse effect on the Company’s consolidated results of operations, balance sheet and/or operating cash flows in the periods recognized or paid. We assumed from Honeywell all health, safety and environmental (“HSE”) liabilities and compliance obligations related to the past and future operations of our current business, as well as all HSE liabilities associated with our manufacturing locations used in our current operations, including any cleanup or other liabilities related to any contamination that may have occurred at such locations in the past. Honeywell retained all HSE liabilities related to former business locations or the operation of our former businesses. Although we have ongoing environmental remedial obligations at certain of our facilities, in the past three years, the associated remediation costs have not been material, and we do not expect our known remediation costs to have a material adverse effect on the Company's consolidated financial position or results of operations. 10. Income Taxes The provision for income taxes was $ 19.2 million and $ 9.3 million for the three months ended March 31, 2022 and 2021, respectively, resulting in an effective tax rate of 23.3 % and 24.8 %, respectively. The Company’s provision for income taxes in interim periods is computed by applying an estimated annual effective tax rate against Income (Loss) before taxes for the period in addition to recording any tax effects of discrete items for the quarter. The Company’s estimated annual effective tax rate applied against the three months ended March 31, 2022 and 2021 differed from the U.S. federal statutory rate, due primarily to state taxes and executive compensation deduction limitations which generally increase the tax rate, partially offset by tax credits and the foreign-derived intangible income deduction which generally decrease the tax rate. In February 2022, the Company acquired the stock of U.S. Amines, Ltd. Under purchase accounting rules, a net deferred tax liability of approximately $ 12.2 million was recorded in the quarter related to the adjustment of the acquired assets and liabilities to fair value. See Note 13 "Acquisitions" for further details. We are subject to income taxes in the United States and to a lesser extent several foreign jurisdictions. Changes to income tax laws and regulations, or the interpretation of such laws, in any of the jurisdictions in which we operate could increase our effective tax rate and reduce our cash flows from operating activities. The current U.S. administration has released various draft tax reform proposals that, if enacted, would generally increase U.S. federal income taxes on corporations. These proposals, if implemented, could have an unfavorable effect on our business, results of operations and financial condition. As such, we continue to monitor these legislative proposals to evaluate the impact on our business. 11. Fair Value Measurements Financial and non-financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. In July 2019, the Company entered into an interest rate swap transaction related to its credit agreement. The fair value of the interest rate swap at March 31, 2022 was a loss of approximately $ 0.04 million and is considered a Level 2 liability. The pension plan assets are invested in collective investment trust funds. These investments are measured at fair value using the net asset value per share as a practical expedient. Investments valued using the net asset value method (NAV) (or its equivalent) practical expedient are excluded from the fair value hierarchy disclosure. The Company’s Condensed Consolidated Balance Sheets also include Cash and cash equivalents, Accounts receivable and Accounts payable all of which are recorded at amounts which approximate fair value. 13 ADVANSIX INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Dollars in thousands, except share and per share amounts and as otherwise noted) The Company also has assets that are required to be recorded at fair value on a non-recurring basis. These assets are evaluated when certain triggering events occur (including a decrease in estimated future cash flows) that indicate the asset should be evaluated for impairment which could result in such assets being measured at fair value. Goodwill must be evaluated at least annually. Our annual evaluation occurred on March 31, 2022 and we concluded that an impairment for goodwill did no t occur. 12. Derivative and Hedging Instruments The specific credit and market, commodity price and interest rate risks to which the Company is exposed in connection with its ongoing business operations are described below. This discussion includes an explanation of the hedging instrument and interest rate swap agreement, used to manage the Company’s interest rate risk associated with a fixed and floating-rate borrowing. For cash flow hedges, the entire change in the fair value of the hedging instrument included in the assessment of hedge effectiveness is recorded in Other comprehensive income. Those amounts are reclassified to earnings in the same income statement line item that is used to present the earnings effect of the hedged item when the hedged item affects earnings. Credit and Market Risk – Financial instruments, including derivatives, expose the Company to counterparty credit risk for non-performance and to market risk related to changes in commodity prices, interest rates and foreign currency exchange rates. The Company manages its exposure to counterparty credit risk through specific minimum credit standards, diversification of counterparties, and procedures to monitor concentrations of credit risk. The Company’s counterparties in derivative transactions are substantial investment and commercial banks with significant experience using such derivative instruments. The Company monitors the impact of market risk on the fair value and cash flows of its derivative and other financial instruments considering reasonably possible changes in commodity prices, interest rates and foreign currency exchange rates and restricts the use of derivative financial instruments to hedging activities. The Company continually monitors the creditworthiness of its customers to which it grants credit terms in the normal course of business. The terms and conditions of credit sales are designed to mitigate or eliminate concentrations of credit risk with any single customer. The Company did not have any customers with significant concentrations of trade accounts receivable – net at March 31, 2022 or December 31, 2021. Allowance for doubtful accounts is calculated based upon the Company's estimate of expected credit losses over the life of exposure based upon both historical information as well as future expected losses. Commodity Price Risk Management – The Company's exposure to market risk for commodity prices can result in changes in the cost of production. We primarily mitigate our exposure to commodity price risk by using long-term, formula-based price contracts with our suppliers and formula-based price agreements with customers. Our customer agreements provide for price adjustments based on relevant market indices and raw material prices and generally do not include take-or-pay terms. We may also enter into forward commodity contracts with third-parties designated as hedges of anticipated purchases of several commodities. Forward commodity contracts are marked-to-market, with the resulting gains and losses recognized in earnings, in the same category as the items being hedged, when the hedged transaction is recognized. At March 31, 2022 and 2021, we had no financial contracts related to forward commodity agreements. Interest Rate Risk Management – The Company has entered into one interest rate swap agreement for a total notional amount of $ 50 million to exchange floating for fixed rate interest payments for our LIBOR-based borrowings. The interest rate swap had a fair value of zero at inception and was effective July 31, 2019 with a maturity date of February 21, 2023. In accordance with ASC 815, the Company designated the interest rate swap as a cash flow hedge of floating-rate borrowings. The interest rate swap converts the Company’s interest rate payments on the first $ 50 million of variable-rate, 1-month LIBOR-based debt to a fixed interest rate. The interest rate swap involves the receipt of floating rate amounts in exchange for fixed rate interest payments over the life of the interest rate swap without an exchange of the underlying principal amount. 14 ADVANSIX INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Dollars in thousands, except share and per share amounts and as otherwise noted) Liability Derivatives March 31, 2022 December 31, 2021 Balance Sheet Classification Fair Value Balance Sheet Classification Fair Value Derivatives designated as hedging instruments under ASC 815: Interest Rate Contracts Accrued liabilities and Other liabilities $ ( 44 ) Accrued liabilities and Other liabilities $ ( 708 ) Total Derivatives $ ( 44 ) $ ( 708 ) The following table summarizes adjustments related to cash flow hedge included in Cash-flow hedges, in the Condensed Consolidated Statements of Comprehensive Income: March 31, 2022 Loss on derivative instruments included in Accumulated other comprehensive loss at December 31, 2021 $ ( 708 ) Fair value adjustment 664 Loss on derivative instruments included in Accumulated other comprehensive loss at March 31, 2022 $ ( 44 ) At March 31, 2022, the Company expects to reclassify approximately $ 0.04 million of net losses on derivative instruments from Accumulated other comprehensive income ("AOCI") to earnings during the next 12 months due to the payment of variable interest associated with the floating rate debt with the remainder recognized in future periods through the expiration date. The following table summarizes the reclassification of net losses on derivative instruments from AOCI into earnings: Amount of Loss Recognized in Earnings Three Months Ended March 31, 2022 2021 Derivatives: Interest Rate Contracts $ 12 $ 557 Total Derivatives $ 12 $ 557 13. Acquisitions In February 2022, the Company acquired U.S. Amines, Ltd. ("U.S. Amines"), a leading North American producer of alkyl and specialty amines serving high-value end markets such as agrochemicals and pharmaceuticals for an estimated purchase price of approximately $ 98 million, net of cash acquired. U.S. Amines employs approximately 50 people in the United States at manufacturing facilities in Bucks, AL and Portsmouth, VA. In accordance with ASC 805, this transaction has been accounted for as a business combination. The Company used its best estimates and assumptions for items including, but not limited to, corporate name recognition, strong, long-lasting customer relationships and potential revenue growth from existing customers to assign fair value to the tangible and identifiable intangible assets acquired and liabilities assumed at the acquisition date based on the information that was available as of the acquisition date. The transaction resulted in the Company acquiring tangible assets and finite-lived intangible assets, comprised of customer relationships (approximately $ 30 million) and trademarks (approximately $ 1 million) which reflect the value of the benefit derived from incremental revenue and related cash flows as a direct result of the customer relationships and name brand. These intangible assets are being amortized on a straight-line basis over their estimated useful lives of 20 years and 5 years, respectively. The residual amount of the purchase price in excess of the value of the tangible and definite-lived intangible assets 15 ADVANSIX INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Dollars in thousands, except share and per share amounts and as otherwise noted) was allocated to goodwill. Factors considered when identifying goodwill included, but are not limited to, a complementary business model and formula pricing mechanisms with a business that is adjacent to our ammonium sulfate adjuvant and solvent businesses, the enhancement of the Company’s value chain through internal supply of products and raw materials, a new unique platform in the agrochemicals space as well as a number of opportunities to support further penetration into high-value applications. The U.S. Amines acquisition was not significant to our Condensed Consolidated Financial Statements, therefore, pro forma and post-acquisition results of operations have not been presented. The preliminary measurements of fair value set forth herein are subject to change and such changes could be material. The Company expects to finalize the valuation as soon as practicable, but no later than one year from the acquisition date. In January 2021, the Company acquired certain assets associated with ammonium sulfate packaging, warehousing and logistics services in Virginia from Commonwealth Industrial Services, Inc. ("CIS") for approximately $ 9.5 million. This acquisition enables the Company to expand its product offerings by directly supplying packaged ammonium sulfate to customers, primarily in North and South America. It diversifies and optimizes our product offerings to include spray-grade adjuvant to support crop protection and products for industrial use. The Company also expects the addition of packaging and warehousing capabilities to bolster logistics and operational efficiency across its Richmond, Virginia area plants. The transaction resulted in the Company acquiring tangible assets and a finite-lived intangible asset, comprised of customer relationships which reflects the value of the benefit derived from incremental revenue and related cash flows as a direct result of the customer relationships. This intangible asset is being amortized on a straight-line basis over its estimated useful life of 15 years. The residual amount of the purchase price in excess of the value of the tangible and definite-lived intangible assets was allocated to goodwill The following table summarizes the allocation of the purchase price consideration as of the acquisition date for the transactions noted above: U.S. Amines (February 2022 - Preliminary) CIS (January 2021) Cash $ 22,887 $ — Accounts receivable 15,117 858 Inventories 11,937 712 Other current assets 1,876 — Property, plant and equipment 13,600 1,875 Intangible assets 31,400 3,920 Accounts payable ( 1,487 ) ( 429 ) Accrued liabilities ( 2,760 ) — Deferred income taxes ( 12,243 ) — Net tangible and intangible assets 80,327 6,936 Goodwill 40,271 2,587 Total purchase price $ 120,598 $ 9,523 Total purchase price $ 120,598 $ 9,523 Less: Cash acquired ( 22,887 ) — Total purchase price, net of cash received 97,711 9,523 Estimated working capital adjustment due from seller 878 — Net cash paid $ 98,589 $ 9,523 Goodwill deductible for tax purposes $ — $ 2,587 14. Subsequent Events As announced on May 6, 2022, the Board declared a quarterly cash dividend of $ 0.125 per share on the Company's common stock, payable on May 31, 2022 to stockholders of record as of the close of business on May 17, 2022. 16